Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 05.10.2026 2 AJNR Am J Neuroradiol 1 Am J Clin Oncol 1 BMC Cancer 1 Cancer 1 Childs Nerv Syst 1 Clin Cancer Res 2 Eur J Cancer 2 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 4 J Neurooncol 1 J Neuropathol Exp Neurol 6 J Neurosurg 1 Mayo Clin Proc 9 Neuro Oncol 1 Neurol Res 1 Neurology 1 Neurosurgery 1 Pediatr Neurol 1 PLoS One 2 Proc Natl Acad Sci U S A 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. SAKAMOTO H, Hashimoto T, Matsushima K, Arai Y, et al
   Prompt volumetric responses following preoperative embolization of skull base meningiomas: association with intratumoral contrast enhancement loss.
   AJNR Am J Neuroradiol. 2026 Oct 2:ajnr.A9661. doi: 10.3174/ajnr.A9661.
   PubMed         Abstract available
   
   
2. BONACCHI R, Calimeri T, Shashkin I, Fiore P, et al
   Decoding MRI Presentation of Primary Central Nervous System Diffuse Large B-Cell Lymphoma: A Novel Subgroup Perspective.
   AJNR Am J Neuroradiol. 2026;47:2580-2588.
   PubMed         Abstract available
   
   

   
   Am J Clin Oncol

3. AYTEHGEZA RS, McClelland S 3rd
   Dose to the Fetus in Pregnant Women Undergoing Stereotactic Radiosurgery for Brain Tumors.
   Am J Clin Oncol. 2026 Sep 28. doi: 10.1097/COC.0000000000001379.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. WANG C, Sun B, Chen S, Kong W, et al
   Integrative transcriptomic and experimental analyses identifies SDF4 as an astrocyte-expressed regulator of glioma progression through PI3K-AKT signaling.
   BMC Cancer. 2026;26:1160.
   PubMed         Abstract available
   
   

   
   Cancer

5. LAWRENCE L
   Tile-based radiation therapy may be new standard of care for patients with surgical brain metastases.
   Cancer. 2026;132:e70575.
   PubMed        
   
   

   
   Childs Nerv Syst

6. KASHEFIOLASL S, Lachner K, Braun CJ, Weber KJ, et al
   Frameless VarioGuide biopsy for pediatric brainstem lesions in the molecular era: diagnostic performance and workflow characteristics in a comparative single-center series.
   Childs Nerv Syst. 2026;42:379.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

7. MA P, Zhou Y, Ma W, Wang Y, et al
   Intrathecal Allogeneic B7-H3-Targeted CAR gammadelta T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunologic Dynamics in a Phase I Trial.
   Clin Cancer Res. 2026;32:4341-4353.
   PubMed         Abstract available
   
   

   
   Eur J Cancer

8. SAIBABA G, Giwa O, Booth TC, Kiskova-Simkova T, et al
   Artificial intelligence for brain cancer management: multimodal digital workflows for diagnosis, treatment planning, and longitudinal monitoring.
   Eur J Cancer. 2026;247:116991.
   PubMed         Abstract available
   
   
9. BLAY JY, Lamure S, Waissi W, Sunyach MP, et al
   Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
   Eur J Cancer. 2026;247:117010.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

10. JEON SH, Kim N, Yoon HI, Wee CW, et al
    Impact of aggressive treatment on outcomes in IDH-wildtype glioblastoma patients with leptomeningeal dissemination.
    Int J Radiat Oncol Biol Phys. 2026 Sep 27:S0360-3016(26)04305.
    PubMed         Abstract available
    
    
11. BAGLEY SJ, Polley MC, Kotecha RR, Brem S, et al
    Tocilizumab, atezolizumab, and stereotactic radiotherapy in recurrent glioblastoma: primary analysis of safety and efficacy of a phase 2 trial, NRG Oncology-BN010.
    Int J Radiat Oncol Biol Phys. 2026 Sep 29:S0360-3016(26)04311.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

12. WEINBERG JS, Imber BS, DiNapoli V, Moss NS, et al
    Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.
    J Clin Oncol. 2026 Sep 28:101200JCO2601894. doi: 10.1200/JCO-26-01894.
    PubMed         Abstract available
    
    

    
    J Neurooncol

13. OZDEMIR Z, Roll W, Stummer W, Kovac S, et al
    [(18)F]FET uptake in diffuse lower-grade IDH-mutant glioma correlates with glioma-related epilepsy.
    J Neurooncol. 2026;180:1.
    PubMed         Abstract available
    
    
14. ZHANG R, Li S, Sun Y, Ma S, et al
    A patient-derived organoid platform for predominantly posterior fossa adult ependymoma: histopathologic preservation, culture-associated transcriptomic remodeling, and in vivo tumorigenicity.
    J Neurooncol. 2026;179:105.
    PubMed         Abstract available
    
    
15. GVALDIN DY, Petrusenko NA, Omelchuk EP, Timoshkina NN, et al
    A novel minimally invasive diagnostic approach of various brain malignancies based on differential miRNA expression.
    J Neurooncol. 2026;179:103.
    PubMed         Abstract available
    
    
16. DUBOIS OA, Loughnan OEL, Jiang Y, Petraello B, et al
    Machine learning and computational approaches to model therapeutic response and resistance in diffuse midline glioma.
    J Neurooncol. 2026;179:104.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

17. HA V, Shelbourn A, Eberhart C, Chiang J, et al
    HOXD12 as an oncofetal protein expressed in WNT-activated medulloblastomas.
    J Neuropathol Exp Neurol. 2026 Sep 29:nlag104. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

18. LAMANO JB, Banu MA, Lee CK, Alvarez AS, et al
    Pituitary adenomas with subarachnoid invasion: clinical characteristics, radiographic features, surgical management, and outcomes.
    J Neurosurg. 2026;145:1057-1068.
    PubMed         Abstract available
    
    
19. PHAM J, Cote DJ, Kang KM, Gomez D, et al
    Incidence and predictors of complications, readmission, and reoperation following endoscopic transsphenoidal surgery for pituitary adenomas.
    J Neurosurg. 2026 Jul 24:1-13. doi: 10.3171/2026.2.JNS252393.
    PubMed         Abstract available
    
    
20. CONSTANTHIN PE, Ferriere A, Sanchez-Gallardo F, Nunes ML, et al
    MRI predictive value for adenoma detection in Cushing's disease and reader dependence: a multi-observer study.
    J Neurosurg. 2026 Jul 31:1-9. doi: 10.3171/2026.2.JNS252331.
    PubMed         Abstract available
    
    
21. TRIPATHY A, Harake ES, Ahmad A, Sharba N, et al
    Predicting postoperative hospice enrollment following stereotactic brain biopsy: a retrospective study and risk score development.
    J Neurosurg. 2026;145:1161-1173.
    PubMed         Abstract available
    
    
22. EPSTEIN S, Asfaw ZK, Young T, Durbin J, et al
    Brain tumor surgery outcomes in rural America: a cross-sectional statewide study.
    J Neurosurg. 2026 Oct 2:1-8. doi: 10.3171/2026.4.JNS252166.
    PubMed         Abstract available
    
    
23. WANG X, Yu T, Zhang X, Zhao X, et al
    Use of structure-function coupling to assess compensatory motor cortex flexibility and predict postoperative motor outcomes in patients with motor area gliomas.
    J Neurosurg. 2026 Oct 2:1-12. doi: 10.3171/2026.4.JNS26181.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

24. MCCARTHY M, Wojcik AA, Barr Fritcher EG, Tekin B, et al
    Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency).
    Mayo Clin Proc. 2026;101:1751-1777.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

25. ABBOUD M, Sisoudiya S, Kaplan B, Elisha T, et al
    Association of high tumor mutational burden with brain metastases: Insights from a large-scale database analysis.
    Neuro Oncol. 2026 Sep 26:noag222. doi: 10.1093.
    PubMed         Abstract available
    
    
26. BARELLI C, Bonfanti M, Mirabella F, Ricca D, et al
    Stem cell morphology defines functional heterogeneity and therapeutic vulnerabilities in glioblastoma.
    Neuro Oncol. 2026 Sep 26:noag235. doi: 10.1093.
    PubMed         Abstract available
    
    
27. KAWAUCHI D, Miyake Y, Taylor B, Bendik J, et al
    SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.
    Neuro Oncol. 2026 Sep 28:noag237. doi: 10.1093.
    PubMed         Abstract available
    
    
28. YAN H, Jin J, Chang Y, Pang B, et al
    H3K27me3 loss and METTL3-m6A converge to upregulate SOX11/SMARCA4 and drive H3K27-altered spinal cord glioma stemness and proliferation.
    Neuro Oncol. 2026 Sep 28:noag232. doi: 10.1093.
    PubMed         Abstract available
    
    
29. 
    Corrigendum to: Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study.
    Neuro Oncol. 2026 Sep 30:noag230. doi: 10.1093.
    PubMed        
    
    
30. CONGIVARAM H, Thirunavu V, Santana-Santos L, Jamshidi P, et al
    An evidence-based workflow for integrating molecular testing with histopathology in the workup of meningiomas.
    Neuro Oncol. 2026 Oct 1:noag217. doi: 10.1093.
    PubMed         Abstract available
    
    
31. ZHANG Y, Chen R, Song Y, Lin Y, et al
    NFAM1 organizes a lipid raft-restricted DAPP1-PLCG2 module to drive M2-like GAM polarization via Ca(2)(+)-NFAT1 signaling in glioma.
    Neuro Oncol. 2026 Oct 1:noag240. doi: 10.1093.
    PubMed         Abstract available
    
    
32. MACCARI M, Marinelli E, Caccese M, Padovan M, et al
    Durable complete response to dual immune checkpoint blockade in an MMR-deficient, Lynch syndrome-associated CNS WHO grade 3 meningioma.
    Neuro Oncol. 2026 Oct 1:noag239. doi: 10.1093.
    PubMed        
    
    
33. ASOGWA OA, Dirven L, van den Bent MJ, Aaronson NK, et al
    Health-Related Quality of Life in Glioma Subtypes: A Pooled Analysis of 16 Randomized Trials from the CODAGLIO 2.0 project.
    Neuro Oncol. 2026 Oct 1:noag231. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

34. YOLDOSHEV J, Qureshi K, Altibayev U, Kariev G, et al
    Silent aspiration and swallowing safety impairment after insular glioma surgery: a prospective FEES-based study.
    Neurol Res. 2026 Sep 25:1-22. doi: 10.1080/01616412.2026.2739317.
    PubMed         Abstract available
    
    

    
    Neurology

35. MERSALI S, Chapelle R, Ribeiro M, Weiss N, et al
    Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.
    Neurology. 2026;107:e218561.
    PubMed         Abstract available
    
    

    
    Neurosurgery

36. TANG A, Bin-Alamer O, Adida S, Fabozzi GL, et al
    Long-Term Outcomes of Endoscopic Endonasal Resection for Tuberculum Sella Meningiomas.
    Neurosurgery. 2026 Oct 1. doi: 10.1227/neu.0000000000004232.
    PubMed         Abstract available
    
    

    
    Pediatr Neurol

37. BUNCIC JR, Malem A, Reginald YA, Tandon A, et al
    When Does Infantile Nystagmus Predict Optic Pathway Glioma?
    Pediatr Neurol. 2026;185:48-51.
    PubMed         Abstract available
    
    

    
    PLoS One

38. ZHANG J, Cai C, Tan X, Chen W, et al
    An efficient brain tumor classification system with accurate recognition and complementary downsampling blocks.
    PLoS One. 2026;21:e0343457.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

39. SHAHI M, Virgin KL, Michaelides L, Moniz Garcia D, et al
    Metabolite ratiomics: Rapid diagnosis and classification of gliomas for intraoperative application during brain surgery.
    Proc Natl Acad Sci U S A. 2026;123:e2616216123.
    PubMed         Abstract available
    
    
40. ASUZU DT, Bhatt D, Mullaney D, Mandal D, et al
    Phosphoproteomic dysregulation promotes tumor proliferation in Cushing's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2528513123.
    PubMed         Abstract available
    
    

    
    Rev Neurol

41. WU S, Wang J, Zhang L, Meng X, et al
    Meningiomas in Elderly Patients: Epidemiology, Clinical Characteristics, Prognostic Factors, and Personalized Treatment Strategies.
    Rev Neurol. 2026;81:53896.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum